首页> 美国卫生研究院文献>Malaria Journal >A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages
【2h】

A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages

机译:抗间日疟原虫UIS4的重组抗体用于区分休眠期和肝期复制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPlasmodium vivax is the most geographically widespread of the human malaria parasites, causing 50,000 to 100,000 deaths annually. Plasmodium vivax parasites have the unique feature of forming dormant liver stages (hypnozoites) that can reactivate weeks or months after a parasite-infected mosquito bite, leading to new symptomatic blood stage infections. Efforts to eliminate P. vivax malaria likely will need to target the persistent hypnozoites in the liver. Therefore, research on P. vivax liver stages necessitates a marker for clearly distinguishing between actively replicating parasites and dormant hypnozoites. Hypnozoites possess a densely fluorescent prominence in the parasitophorous vacuole membrane (PVM) when stained with antibodies against the PVM-resident protein Upregulated in Infectious Sporozoites 4 (PvUIS4), resulting in a key feature recognizable for quantification of hypnozoites. Thus, PvUIS4 staining, in combination with the characteristic small size of the parasite, is currently the only hypnozoite-specific morphological marker available.
机译:背景间日疟原虫是人类疟疾寄生虫中地理分布最广泛的,每年造成50,000至100,000例死亡。间日疟原虫寄生虫具有形成休眠肝脏阶段(子裂殖体)的独特特征,该阶段可以在寄生虫感染蚊子叮咬后数周或数月重新激活,从而导致新的症状性血液阶段感染。消除间日疟原虫疟疾的工作可能需要针对肝脏中持续存在的次生动物。因此,对间日疟原虫肝阶段的研究需要一个标记物,以清楚地区分活跃复制的寄生虫和休眠的次生子。裂殖子在抗传染性子孢子4(PvUIS4)中上调的PVM驻留蛋白抗体染色后,在寄生虫的液泡膜(PVM)中具有密集的荧光突出,从而导致了重要的特征可用于定量定殖子。因此,PvUIS4染色与寄生虫的特征性小尺寸相结合,是目前唯一可用的裂殖子特异性形态学标记。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号